J. Leonard Lichtenfeld

Aug 3, 2024 | kevinmd.com | Wendy Levinson |Christine Soong |J. Leonard Lichtenfeld |Sarah Alnaher

Today, I want to talk about how creative humans are. As physicians, we encounter patients with ideas that amaze us every day and make our lives interesting, to say the least. The best ones are often the elderly, who have years of experience and unique ways of getting things done that differ greatly from the current generation. I came across an elderly patient in the office who had previously been diagnosed with ADHD but did not take his medication because he felt he did not need it.

Apr 18, 2024 | kevinmd.com | C. Nicole Swiner |Michael Milobsky |J. Leonard Lichtenfeld |Christina Adams

I’ve been inspired by a recent New York Times article that came out about IUDs, better known as intrauterine devices, and how painful and horrible some of the experiences for women have been over the years. Since writing some of these thoughts, I saw that a Cosmopolitan article recently chimed in on the topic.

Dec 27, 2023 | kevinmd.com | L. Joseph Parker |Amanda Xi |Lynn Marie Morski |J. Leonard Lichtenfeld

The German pharmaceutical company Grunenthal has announced the start of a human addiction potential (HAP) trial of a first-in-class analgesic called cebranopadol, described as “less addictive” than previous medications. We’ve been down this road before. This medication is both a mu-opioid peptide and nociptin/orphanin FQ peptide (NOP) receptor agonist. I must confess I had to look up the last one.